Stifel Nicolaus Downgrades Idenix Pharmaceuticals (IDIX) to Sell
Tweet
Share
E-mailGet Alerts IDIX Hot Sheet
Price: $24.50 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel Nicolaus downgraded Idenix Pharmaceuticals (NASDAQ: IDIX) from Hold to Sell.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $14.33 yesterday.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $14.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- Oculis Holding AG (OCS) Reiterated at Buy by Stifel After CEO Chat
- Celcuity Inc (CELC) PT Lowered to $150 at Stifel as Gedatolisib Distribution Initiated
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
